These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27889930)

  • 1. Receptor tyrosine kinase amplification is predictive of distant metastasis in patients with oral squamous cell carcinoma.
    Oikawa Y; Morita KI; Kayamori K; Tanimoto K; Sakamoto K; Katoh H; Ishikawa S; Inazawa J; Harada H
    Cancer Sci; 2017 Feb; 108(2):256-266. PubMed ID: 27889930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted next-generation sequencing of 50 cancer-related genes in Japanese patients with oral squamous cell carcinoma.
    Nakagaki T; Tamura M; Kobashi K; Omori A; Koyama R; Idogawa M; Ogi K; Hiratsuka H; Tokino T; Sasaki Y
    Tumour Biol; 2018 Sep; 40(9):1010428318800180. PubMed ID: 30226113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
    Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
    Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma.
    Kozaki K; Imoto I; Pimkhaokham A; Hasegawa S; Tsuda H; Omura K; Inazawa J
    Cancer Sci; 2006 Dec; 97(12):1351-8. PubMed ID: 17052259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of oral squamous cell carcinoma using targeted next-generation sequencing.
    Er TK; Wang YY; Chen CC; Herreros-Villanueva M; Liu TC; Yuan SS
    Oral Dis; 2015 Oct; 21(7):872-8. PubMed ID: 26173098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
    Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Kim HR; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC
    Oncotarget; 2016 May; 7(21):30691-701. PubMed ID: 27095573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
    Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
    Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
    Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
    Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma.
    Ma J; Fu Y; Tu YY; Liu Y; Tan YR; Ju WT; Pickering CR; Myers JN; Zhang ZY; Zhong LP
    BMC Cancer; 2018 Jul; 18(1):758. PubMed ID: 30041611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.
    Chau NG; Li YY; Jo VY; Rabinowits G; Lorch JH; Tishler RB; Margalit DN; Schoenfeld JD; Annino DJ; Goguen LA; Thomas T; Becker H; Haddad T; Krane JF; Lindeman NI; Shapiro GI; Haddad RI; Hammerman PS
    Clin Cancer Res; 2016 Jun; 22(12):2939-49. PubMed ID: 26763254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant GDF15 presents a poor prognostic outcome for patients with oral squamous cell carcinoma.
    Ma J; Tang X; Sun WW; Liu Y; Tan YR; Ma HL; Zhu DW; Wang M; Wang LZ; Li J; Tu YY; Zhang CP; Zhang ZY; Zhong LP
    Oncotarget; 2016 Jan; 7(2):2113-22. PubMed ID: 26544895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
    Ali SM; Pal SK; Wang K; Palma NA; Sanford E; Bailey M; He J; Elvin JA; Chmielecki J; Squillace R; Dow E; Morosini D; Buell J; Yelensky R; Lipson D; Frampton GM; Howley P; Ross JS; Stephens PJ; Miller VA
    Oncologist; 2016 Jan; 21(1):33-9. PubMed ID: 26670666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases.
    Allison DB; Lilo MT; Geddes S; Pallavajjalla A; Askin F; Gabrielson E; Zheng G; Li QK
    Cancer Cytopathol; 2016 Jul; 124(7):485-92. PubMed ID: 27007084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma.
    Trietsch MD; Spaans VM; ter Haar NT; Osse EM; Peters AA; Gaarenstroom KN; Fleuren GJ
    Gynecol Oncol; 2014 Oct; 135(1):149-55. PubMed ID: 25072932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined mutational analysis of RAS, BRAF, PIK3CA, and TP53 genes in Taiwanese patients with oral squamous cell carcinoma.
    Chang YS; Hsu HT; Ko YC; Yeh KT; Chang SJ; Lin CY; Chang JG
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jul; 118(1):110-116.e1. PubMed ID: 24908601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue.
    Yokota T; Serizawa M; Hosokawa A; Kusafuka K; Mori K; Sugiyama T; Tsubosa Y; Koh Y
    BMC Cancer; 2018 Aug; 18(1):826. PubMed ID: 30115035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of PTEN/PIK3CA/AKT pathway in oral squamous cell carcinoma.
    Cohen Y; Goldenberg-Cohen N; Shalmon B; Shani T; Oren S; Amariglio N; Dratviman-Storobinsky O; Shnaiderman-Shapiro A; Yahalom R; Kaplan I; Hirshberg A
    Oral Oncol; 2011 Oct; 47(10):946-50. PubMed ID: 21824802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy.
    Ali SM; Yao M; Yao J; Wang J; Cheng Y; Schrock AB; Chirn GW; Chen H; Mu S; Gay L; Elvin JA; Suh J; Miller VA; Stephens PJ; Ross JS; Wang K
    Cancer; 2017 Sep; 123(18):3628-3637. PubMed ID: 28581676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterations.
    Ross JS; Wang K; Khaira D; Ali SM; Fisher HA; Mian B; Nazeer T; Elvin JA; Palma N; Yelensky R; Lipson D; Miller VA; Stephens PJ; Subbiah V; Pal SK
    Cancer; 2016 Mar; 122(5):702-11. PubMed ID: 26651075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.